Tranexamic Acid Therapeutic Cheat Sheet
Tranexamic acid (TXA) is a synthetic lysine derivative that reversibly blocks the lysine-binding site on plasminogen, preventing conversion to plasmin. While originally developed as an antifibrinolytic agent to reduce bleeding, TXA has several downstream effects that make it useful in dermatology, particularly for pigmentary disorders, with emerging evidence in inflammatory disorders as well. TX …
Tranexamic acid (TXA) is a synthetic lysine derivative that reversibly blocks the lysine-binding site on plasminogen, preventing conversion to plasmin. While originally developed as an antifibrinolytic agent to reduce bleeding, TXA has several downstream effects that make it useful in dermatology, particularly for pigmentary disorders, with emerging evidence in inflammatory disorders as well. TX … 
The fourth Pigmentary Disorders Exchange (PDE) Symposium opened with a powerful call to action to advance the science of pigmentary disorders with purpose, hope, and humanity, challenging clinicians to move these conditions from "invisible" to the center stage of medical priority. Experts emphasized that pigmentary diseases are not merely cosmetic concerns but complex medical disorders that inters … 
The laser toolbox for use in patients with skin of color has grown dramatically in the last 20 years. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Paul M. Friedman, clinical assistant professor of dermatology at the University of Texas Medical School. Dr. Friedman practices in Houston, the most ethnically diverse city in America, so he’s become well-versed in th … 
Effective acne management in skin of color requires a dual approach: treating the active lesions while simultaneously addressing post-inflammatory hyperpigmentation (PIH). Drawing from an expert, case-based session led by Dr. Hilary Baldwin and Dr. Andrew Alexis at the Skin of Color Update, this summary breaks down their practical strategies for managing this overlapping clinical challenge.
The … 
For dermatology clinicians, staying at the forefront of therapeutic advances is essential, especially when it comes to conditions that carry profound psychosocial burdens for patients. Few areas in dermatology are evolving as rapidly, or demand as much clinical nuance, as the study and treatment of pigmentary disorders.
To dive deeper into these complexities, our friends at Practical Dermatology …